|
EP1622886A2
(en)
|
2003-04-30 |
2006-02-08 |
The Institutes for Pharmaceutical Discovery, LLC |
Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
|
|
US7601712B2
(en)
|
2003-09-17 |
2009-10-13 |
Ono Pharmaceutical Co., Ltd. |
Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
|
|
WO2005105736A1
(en)
|
2004-05-05 |
2005-11-10 |
Novo Nordisk A/S |
Novel compounds, their preparation and use
|
|
ES2352085T3
(es)
|
2004-05-05 |
2011-02-15 |
High Point Pharmaceuticals, Llc |
Nuevos compuestos, su preparación y uso.
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
WO2006019831A1
(en)
|
2004-07-14 |
2006-02-23 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US7868037B2
(en)
|
2004-07-14 |
2011-01-11 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
WO2006019832A1
(en)
|
2004-07-22 |
2006-02-23 |
Ptc Therapeutics, Inc. |
Thienopyridines for treating hepatitis c
|
|
JP2008520693A
(ja)
|
2004-11-18 |
2008-06-19 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
プロテインチロシンホスファターゼ阻害剤としての置換アミノ酸
|
|
JP2008520692A
(ja)
*
|
2004-11-18 |
2008-06-19 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
複素環置換カルボン酸
|
|
EP1836182A2
(en)
*
|
2004-11-18 |
2007-09-26 |
The Institutes for Pharmaceutical Discovery, LLC |
Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors
|
|
DE102004060542A1
(de)
*
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
WO2006117657A1
(en)
*
|
2005-05-03 |
2006-11-09 |
Ranbaxy Laboratories Limited |
Triazolone derivatives as anti-inflammatory agents
|
|
ATE529404T1
(de)
|
2005-06-30 |
2011-11-15 |
High Point Pharmaceuticals Llc |
Phenoxyessigsäuren als ppar-delta-aktivatoren
|
|
US8097610B2
(en)
|
2005-08-26 |
2012-01-17 |
Shionogi & Co., Ltd. |
Derivative having PPAR agonistic activity
|
|
BRPI0620468A2
(pt)
|
2005-12-22 |
2011-11-08 |
Transtech Pharma, Inc. |
ácidos fenóxi acéticos como ativadores de ppar delta
|
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
|
WO2007101864A2
(en)
|
2006-03-09 |
2007-09-13 |
High Point Pharmaceuticals, Llc |
Compounds that modulate ppar activity, their preparation and use
|
|
WO2008033934A1
(en)
*
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted heteroaryl carboxylic acid derivatives as ptb-1b inhibitors
|
|
WO2008033931A1
(en)
*
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib
|
|
EP2170339B1
(en)
|
2007-06-27 |
2014-10-15 |
Merck Sharp & Dohme Corp. |
Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
|
|
AU2008269154B2
(en)
|
2007-06-27 |
2014-06-12 |
Merck Sharp & Dohme Llc |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
AU2008335709A1
(en)
*
|
2007-12-13 |
2009-06-18 |
Amgen Inc. |
Gamma secretase modulators
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
JP5752691B2
(ja)
|
2009-09-29 |
2015-07-22 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
新規化合物
|
|
DE102009046115A1
(de)
|
2009-10-28 |
2011-09-08 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 3-Phenylpropansäuren und ihre Verwendung
|
|
JP5814031B2
(ja)
*
|
2010-07-30 |
2015-11-17 |
ユー・ディー・シー アイルランド リミテッド |
有機電界発光素子、及びジベンゾチオフェン構造又はジベンゾフラン構造を有する有機電界発光素子用材料
|
|
CN102382037B
(zh)
*
|
2010-09-03 |
2016-01-20 |
中国医学科学院药物研究所 |
苯丙酸类化合物及其制法和药物用途
|
|
US9107983B2
(en)
|
2010-10-27 |
2015-08-18 |
Warsaw Orthopedic, Inc. |
Osteoconductive matrices comprising statins
|
|
US8877221B2
(en)
|
2010-10-27 |
2014-11-04 |
Warsaw Orthopedic, Inc. |
Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
|
|
PH12013501143A1
(en)
|
2010-12-07 |
2013-07-08 |
Bayer Ip Gmbh |
Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
|
|
NZ611529A
(en)
|
2010-12-23 |
2015-06-26 |
Pfizer |
Glucagon receptor modulators
|
|
WO2012107850A1
(en)
|
2011-02-08 |
2012-08-16 |
Pfizer Inc. |
Glucagon receptor modulator
|
|
DE102011007272A1
(de)
|
2011-04-13 |
2012-10-18 |
Bayer Pharma Aktiengesellschaft |
Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
|
|
US9308190B2
(en)
|
2011-06-06 |
2016-04-12 |
Warsaw Orthopedic, Inc. |
Methods and compositions to enhance bone growth comprising a statin
|
|
US8927577B2
(en)
|
2011-07-22 |
2015-01-06 |
Pfizer Inc. |
Quinolinyl glucagon receptor modulators
|
|
DE102012208530A1
(de)
|
2012-05-22 |
2013-11-28 |
Bayer Pharma AG |
Substituierte Piperidinoacetamide und ihre Verwendung
|
|
EP3013796B9
(en)
*
|
2013-06-27 |
2020-07-01 |
LG Chem, Ltd. |
Biaryl derivatives as gpr120 agonists
|
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
|
US20170119776A1
(en)
|
2014-04-03 |
2017-05-04 |
Bayer Pharma Aktiengesellschaft |
Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof
|
|
US20170022171A1
(en)
|
2014-04-03 |
2017-01-26 |
Bayer Pharma Aktiengesellschaft |
2,5-disubstituted cyclopentanecarboxylic acids and their use
|
|
CA2944614A1
(en)
|
2014-04-03 |
2015-10-08 |
Bayer Pharma Aktiengesellschaft |
2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratoy tract diseases
|
|
MX388871B
(es)
|
2014-06-27 |
2025-03-20 |
Nogra Pharma Ltd |
Moduladores del receptor arilo y metodos para elaborar y usar los mismos.
|
|
CU24413B1
(es)
|
2014-12-18 |
2019-05-03 |
Bayer Pharma AG |
Ácidos piridil-cicloalquil-carboxílicos sustituidos útiles para el tratamiento de enfermedades asociadas al dolor, y para el tratamiento o profilaxis de los síndromes del dolor, de la endometriosis, la adenomiosis y el cáncer
|
|
US10905667B2
(en)
|
2018-07-24 |
2021-02-02 |
Bayer Pharma Aktiengesellschaft |
Orally administrable modified-release pharmaceutical dosage form
|
|
CN116693514A
(zh)
*
|
2022-03-01 |
2023-09-05 |
上海璎黎药业有限公司 |
一类芳香环取代的甲氧基衍生物及其用途
|